---

GROUP-B SAQ ANSWERS (Community Medicine / Public Health)

---

Q1. Fever with Rash in Under-Five Children - Surveillance, Outbreak Investigation, Control (1+6+3=10)

Surveillance System (1 mark)

Steps of Outbreak Investigation (6 marks)

• Conduct a medical survey (house-to-house) to find all cases including those who have not sought care.
• Use a standardized epidemiological case sheet (case definition, date of onset, age, sex, vaccination status, school/residence).
• Apply a working case definition (e.g., for measles: fever + generalized maculopapular rash + one of cough/coryza/conjunctivitis).
• Search for additional cases: contacts at schools, anganwadis, neighbourhood clusters.
• Continue the search until the area is declared epidemic-free (usually twice the incubation period after the last case).

• Time: Plot an epidemic curve (date of onset on x-axis, number of cases on y-axis). A steep single-peaked curve suggests a common source; a propagated curve with successive peaks suggests person-to-person spread - typical for measles.
• Place: Prepare a spot map. Identify clustering around schools, anganwadis, or specific neighbourhoods.
• Person: Analyze by age, sex, immunization status. Calculate age-specific and vaccination status-specific attack rates. Most cases in un-vaccinated or partially vaccinated children indicate vaccine preventable aetiology.

Control Measures (3 marks)

1. Immediate case management: Isolate confirmed cases at home or facility. Treat complications (pneumonia, encephalitis, diarrhoea). Vitamin A supplementation for all measles cases.
2. Ring vaccination / mop-up immunization: Vaccinate all susceptible children (un-vaccinated and partially vaccinated) in the affected block with MMR/MR vaccine. Conduct catch-up vaccination camps at schools and anganwadis.
3. Outbreak containment: Identify and vaccinate all contacts within 72 hours of exposure (post-exposure prophylaxis). Inform schools and anganwadi workers to monitor for new cases.
4. Surveillance intensification: Enhance daily/weekly IDSP reporting from sub-centres and PHCs. Track secondary cases.
5. Health education: Inform communities about the disease, its mode of spread, and the importance of vaccination.
6. Review immunization programme: Identify coverage gaps, cold chain failures, or missed sessions and correct them immediately.

---

Q2. AEFI - Classification with Examples + Health Managerial Functions (5+5=10)

Classification of AEFI (5 marks)

• Mild (Minor/Local): Local tenderness, redness, swelling at injection site; mild fever (<38.5°C); irritability. Example: Local reaction after DPT.
• Moderate: Fever >38.5°C, persistent crying >3 hours, hypotonic hyporesponsive episode (HHE). Example: High fever after pentavalent vaccine.
• Severe (Serious): Anaphylaxis, encephalopathy, vaccine-associated paralytic polio (VAPP), intussusception (after rotavirus vaccine), abscess. Requires hospitalization or results in disability/death.

• Serious AEFI: Results in death, hospitalization, permanent disability.
• Cluster AEFI: Two or more cases of the same event in the same area/time - suggests immunization error.

Health Managerial Functions to Address the Problem (5 marks)

1. Immediate Response:
   • Form an AEFI Investigation Committee at block level. Investigate each reported AEFI within 24-48 hours using the standard AEFI investigation form.
   • Identify the causality category (is it vaccine product, immunization error, coincidental?).
   • Provide prompt medical management to affected individuals (anaphylaxis kit at every vaccination site is mandatory).
2. Reporting and Communication:
   • Report all serious AEFIs to the District Immunization Officer and State Immunization Officer via the national AEFI reporting system (within 24 hours for serious events).
   • If a cluster is identified, suspect and investigate immunization errors immediately.
3. Root Cause Analysis:
   • If immunization error: Inspect cold chain, vial handling, reconstitution technique, injection practices, and expiry dates.
   • Retrain ANMs/health workers in correct vaccine preparation, administration, and reconstitution technique.
   • Check if auto-disable (AD) syringes are being used and disposed of properly.
4. Community Communication (Risk Communication):
   • Hold community meetings with village leaders, panchayat members, and mothers to address fears and misinformation.
   • Explain that most AEFIs are mild and temporary, and that risks of the disease far outweigh vaccine risks.
   • Involve respected community members (teachers, ASHA workers) in trust-building.
5. Restoring Confidence and Reducing Dropout:
   • Conduct house-to-house visits to identify and counsel dropouts.
   • Organise catch-up immunization sessions at convenient locations and timings.
   • Maintain defaulter tracking through ANMOL/RCH portal.
6. Monitoring and Evaluation:
   • Strengthen AEFI surveillance: ensure every sub-centre reports monthly (even if zero cases).
   • Review and analyse immunization coverage data regularly.
   • Feedback findings to all workers; recognize good performance.

---

Q3. National Immunization Schedule for Infants + Polio Eradication Strategies (6+4=10)

National Immunization Schedule for Infants (6 marks)

Strategies for Eradication of Poliomyelitis (4 marks)

• Administration of OPV (bOPV - bivalent types 1 and 3) and IPV through the UIP at 6, 10, 14 weeks and 9 months as part of the routine schedule.
• IPV was introduced to build intestinal immunity and address VAPP risk.

• Supplementary immunization activities (SIAs) targeting all children under 5 years regardless of vaccination history - "pulse" administration on fixed days twice yearly. This strategy saturates the susceptible pool rapidly.

• Sub-national immunization days (SNIDs) targeting high-risk blocks or districts with lower coverage.
• "Mop-up" campaigns in areas where wild poliovirus circulates.

• Active surveillance for AFP in children under 15 years. At least 2 stool samples must be collected within 14 days of onset. Lab testing at WHO-accredited labs to detect wild poliovirus (WPV).
• Non-polio AFP rate ≥2/100,000 children under 15 years is the surveillance quality indicator.

• Rapid response with mop-up vaccination campaigns within 72 hours of detecting a case.
• Environmental (sewage) surveillance in high-risk areas.

• Switch from tOPV to bOPV (April 2016 globally) after eradication of type 2 WPV - reduces the risk of cVDPV type 2.
• IPV introduced to maintain humoral immunity after OPV withdrawal phases.

---

Q4. Investigation of a Food Poisoning Outbreak in a Hostel (10 marks)

• Visit the hostel immediately. Collect information on: total number of affected persons, onset times, symptoms (vomiting, diarrhoea, fever, abdominal cramps), duration, and severity.
• Admit seriously ill cases to hospital. Collect stool, vomit, and blood specimens from cases before any treatment if possible.

• Apply a case definition (e.g., "any person who ate at the hostel mess between [date range] and developed two or more symptoms of nausea, vomiting, diarrhoea, or abdominal pain within 72 hours").
• Confirm through clinical examination and lab testing (stool culture, serology).

• List all persons who ate in the hostel mess during the suspected exposure period (the "population at risk").

• Administer a questionnaire to all hostel residents: symptoms, onset date/time, foods eaten at each meal, beverages consumed.
• Identify cases among those who ate in the mess, and also check those who did not eat in the mess (controls).

• Collect food samples from remaining meals, stored ingredients, and water samples from the mess.
• Inspect the kitchen: food storage temperatures, cooking practices, personal hygiene of food handlers, pest control, drainage.
• Swabs from food-contact surfaces.
• Examine stool samples of food handlers for carrier status.

• Time: Plot the epidemic curve (time of onset). A sharp, single-peaked epidemic curve following a specific meal strongly suggests a common-source (single-meal) food poisoning.
• Place: Are all cases from the same mess/dining hall?
• Person: Calculate food-specific attack rates for each food item served at each meal:

• Incubation period helps identify the agent:
  • 1-6 hours: Staphylococcus aureus (toxin); Bacillus cereus (emetic type)
  • 8-16 hours: Clostridium perfringens; B. cereus (diarrhoeal)
  • 18-72 hours: Salmonella, E. coli, Campylobacter

  • 72 hours: Typhoid, Hepatitis A

• Suspend implicated food items immediately.
• Decontaminate and thoroughly clean the kitchen.
• Temporarily remove food handlers found to be carriers/ill.
• Ensure safe food storage (refrigeration below 5°C or hot-holding above 60°C).
• Safe water supply to the mess.
• Treat affected cases (ORS, antibiotics if indicated).
• Report to the Food Safety Officer (FSSAI), District Health Officer, and municipality under the Prevention of Food Adulteration Act / Food Safety and Standards Act (FSSA 2006).

---

Q5. Fever, Runny Nose, Red Eyes, Rashes in Under-Fives in Urban Slum - Investigation and Control (5+5)

Investigation (5 marks)

1. Verify diagnosis: Examine cases clinically; collect blood for measles IgM (ELISA), throat/nasal swab for viral isolation if available.
2. Confirm outbreak: Compare observed cases with expected baseline - in an urban slum, any cluster of ≥2 linked measles cases constitutes an outbreak.
3. Define population at risk: Map the slum area; conduct a census of under-five children; enumerate vaccination status from MCRS/health cards.
4. Case search: House-to-house survey in the slum. Apply standard case definition (fever + rash + one of: coryza, cough, conjunctivitis). Enumerate all cases, dates of onset, age, sex, immunization history.
5. Data analysis: Plot epidemic curve (expect a propagated curve with successive peaks 10-14 days apart, = measles incubation period). Spot map for geographic clustering. Calculate attack rates by age group and vaccination status. An attack rate highest in unvaccinated children confirms vaccine-preventable aetiology.
6. Lab confirmation: Send paired serum samples (acute + convalescent). Urine/throat swabs for viral isolation.
7. Notify: Report to State Disease Surveillance Unit (SDSU) under IDSP; notify Kolkata Municipal Corporation's Health Department.

Control Measures (5 marks)

1. Case management: Isolate cases at home for 4 days after rash onset. Treat complications. Vitamin A supplementation (1,00,000 IU for infants 6-12 months; 2,00,000 IU for children >12 months) - reduces measles mortality by 50%.
2. Outbreak response immunization (ORI): Vaccinate all children 6 months to 5 years in the affected area with MR vaccine, irrespective of prior vaccination status. Target ≥95% coverage in the area.
3. Post-exposure prophylaxis: Vaccinate unvaccinated contacts within 72 hours of exposure.
4. Health education: Use ASHA, community workers, and local media to educate parents about measles symptoms, isolation, and vaccine safety.
5. Strengthening routine immunization: Review immunization coverage data. Identify and address cold chain failures, missed sessions. Increase fixed and outreach immunization sessions in the slum.
6. Intensified surveillance: Daily line listing of new cases for 2 incubation periods (42 days) after the last case.

---

Q6. Retrospective Cohort Study - Relative Risk Calculation (1+1+2=4 marks) [Note: question appears to be a 4-mark subset]

Definition of Relative Risk (1 mark)

Two Advantages of Cohort Study (1 mark)

1. Directly calculates incidence rates and relative risk (true risk estimation) - the gold standard for RR.
2. Suitable for rare exposures (e.g., occupational exposures like silica dust); can study multiple outcomes from a single exposure.

Calculation of RR (2 marks)

• Incidence in exposed = 120/800 = 0.150 (15%)
• Incidence in non-exposed = 30/1200 = 0.025 (2.5%)

---

Q7. Define Epidemic + Types + Epidemiological Investigation of Rash and Fever (2+2+6)

Definition of Epidemic (2 marks)

Types of Epidemics (2 marks)

1. Common-source epidemic:
   • Single-exposure (point source): All cases exposed at one point in time. Sharp, peaked epidemic curve. Example: food poisoning at a banquet.
   • Continuous/prolonged source: Exposure continues over time. Example: contaminated water supply.
   • Intermittent source: Exposure occurs irregularly. Example: periodic contamination of a water source.
2. Propagated (host-to-host) epidemic: Spread from person to person. Successive waves on the epidemic curve, each separated by the incubation period. Example: measles, influenza, COVID-19.
3. Mixed epidemic: Starts as common-source, then propagates. Example: Cholera (initial water-borne, then person-to-person).

• Outbreak: Small, localized epidemic.
• Epidemic: Wider geographic spread.
• Pandemic: Global spread. Example: COVID-19, Influenza 1918.

Epidemiological Investigation of Rash and Fever in Children, Howrah District (6 marks)

1. Verify diagnosis - Clinical features suggest measles (fever, rash, coryza, Koplik spots); confirm with IgM serology.
2. Confirm epidemic - Compare observed vs. expected cases in Howrah district block; report under IDSP/EWARS.
3. Define population at risk - Map the block; enumerate under-five children; collect vaccination status from MCRS data.
4. Case finding - House-to-house survey; apply measles case definition; contact schools, anganwadis; prepare line list (age, sex, onset date, vaccination status).
5. Data analysis:
   • Time: Epidemic curve - likely propagated (measles) with 10-14 day inter-peak intervals.
   • Place: Spot map; identify clustering in schools/anganwadis.
   • Person: Age-specific and vaccination-status-specific attack rates.
6. Formulate hypothesis: Likely measles outbreak due to accumulation of susceptibles from immunization gaps.
7. Test hypothesis: Compare attack rates: vaccinated vs. unvaccinated children.
8. Control: Outbreak response immunization; case isolation; Vitamin A; strengthened routine immunization; intensified surveillance. Notify District CMO and State Health Department.

---

Q8. Fever, Jaundice After Village Fair - Hepatitis A Outbreak (2+5+3)

Most Probable Diagnosis (2 marks)

• Age group 5-10 years
• Fever, anorexia (loss of appetite), nausea (prodromal phase)
• Jaundice (icterus - yellowish discoloration of eyes and skin)
• Occurring 2 weeks after exposure to contaminated street food (fuchka, golgappa, jhalmuri - all made with water and raw vegetables)
• Typical incubation period of Hepatitis A: 15-50 days (mean 28-30 days)

Steps of Investigation (5 marks)

1. Verify diagnosis: Clinical examination; blood tests - LFT (elevated bilirubin, transaminases), anti-HAV IgM (confirmatory), urine for bilirubin.
2. Confirm outbreak and define cases: Apply case definition: "Any child 5-10 years with acute onset of fever + jaundice from the affected village(s) within [time period]." Count all cases. An outbreak exists if cases exceed baseline.
3. Epidemiological investigation:
   • Prepare a line list of all cases: name, age, date of onset, food items eaten at/before the fair, water source used.
   • Plot an epidemic curve: onset dates relative to the fair. A single peak 2-4 weeks post-fair exposure suggests a common-source.
4. Environmental investigation:
   • Identify all food stalls at the fair; trace suppliers of water, ingredients (tamarind water, chutneys used in fuchka/jhalmuri).
   • Collect water samples from the fair site and nearby wells/hand pumps.
   • Stool samples from food handlers (HAV PCR/IgM).
   • Inspect drainage and sanitation around the fair ground.
5. Food-specific attack rates: Determine which food item is most strongly associated with illness (highest attack rate in those who ate it vs. not).
6. Notify: Report to District Health Officer and municipality under IDSP and Epidemic Diseases Act.

Control Measures (3 marks)

1. Case management: Supportive treatment (rest, oral hydration, high carbohydrate diet, avoid hepatotoxic drugs/alcohol). Hospitalize severe cases (coagulopathy, encephalopathy).
2. Isolation: Isolate jaundiced cases at home for at least 2 weeks from onset of jaundice (or 1 week from onset of illness).
3. Safe water and food: Chlorinate/boil water supply. Prohibit implicated food stalls. Disinfect contaminated water sources with chlorine.
4. Contact prophylaxis: Hepatitis A vaccine or Normal Human Immunoglobulin (NHIG) for close contacts within 2 weeks of exposure.
5. Health education: Emphasize hand hygiene, safe water, cooking of food.

Prevention of Recurrence (included in 3 marks above):

• Safe water supply to the affected village (piped chlorinated water).
• Regulation of temporary food stalls at fairs - mandatory use of safe/treated water, prohibition of raw water in food preparation.
• Food safety inspections under FSSAI at fairs and melas.
• Hepatitis A vaccination for school-age children in endemic areas.
• Sanitation improvement (toilets, handwashing facilities at fairs).
• Health education to community and food handlers.

---

Q9. Control, Elimination, Eradication + MR Campaign (3+1+3+3=10)

Definitions (3 marks)

• Control: Reduction of disease incidence, prevalence, morbidity, or mortality to a locally acceptable level as a result of deliberate efforts. Continued measures are required. Example: control of tuberculosis, malaria.
• Elimination: Reduction of disease incidence or prevalence to zero in a defined geographic area (but not globally). The causative agent may still exist elsewhere. Continued interventions required. Example: Neonatal tetanus elimination (NNT), Lymphatic filariasis elimination from India.
• Eradication: Permanent reduction to zero of the worldwide incidence of infection caused by a specific agent as a result of deliberate efforts, with no further need for control measures. The agent no longer exists in nature. Example: Smallpox (1980), Rinderpest (2011). Polio global eradication is ongoing (only cVDPV2 remains).

Objectives of MR Campaign (1 mark)

Target Population and Strategies (3 marks)

• All children aged 9 months to <15 years (regardless of prior vaccination status) - approximately 41 crore children in India.
• Sub-national campaigns are targeted at districts/states with low MCV coverage or high reported measles burden.

1. Supplementary Immunization Activity (SIA): Conduct MR vaccination campaigns through schools (school-based strategy) and session sites for out-of-school children. Aim: reach ≥95% of target children in a defined time period.
2. Integration with routine immunization: Add MR vaccine to the UIP schedule at 9 months and 16-24 months (MR1 and MR2).
3. Case-based surveillance: Strengthen measles and CRS case-based surveillance with laboratory confirmation at State Measles Laboratories (VRDL network).
4. Social mobilisation: IEC/BCC campaigns; involvement of ASHAs, ANMs, school teachers.
5. Monitoring and accountability: Rapid coverage monitoring, independent monitoring by NHM, and district-level data review.

Role of MR Campaign in Measles Elimination and Rubella/CRS Control (3 marks)

1. Closing immunity gaps: The MR campaign rapidly immunized children who missed routine doses or received only measles vaccine (not rubella). This closes the "immunity debt" accumulated over years - a critical driver of large measles outbreaks.
2. Interrupting measles transmission: By achieving herd immunity threshold (≥95% coverage) across all age groups simultaneously, the campaign interrupts the chain of measles transmission. The WHO's measles elimination definition requires <1 case/million population/year.
3. Rubella and CRS control: Before MR campaign, rubella vaccine was not in the UIP. The campaign introduced rubella immunity in the population - especially important for girls/women of childbearing age who were immunized as children. This reduces the risk of rubella infection in pregnancy, which causes CRS (congenital heart disease, cataracts, deafness, microcephaly).
4. India's progress: India targeted MR elimination by 2023 as part of WHO SEAR regional goal. The phased MR campaign (2017 onwards) immunized over 36 crore children across multiple states, significantly reducing measles cases and CRS burden.

---

Q10. Comparing Two Drugs for Hypertension - Study Design, Steps, Biases (1+6+3=10)

Appropriate Study Design (1 mark)

Steps in Conducting the Study (6 marks)

1. Define Research Question and Hypothesis: Null hypothesis: "There is no significant difference in blood pressure reduction between Drug A and Drug B." Alternative hypothesis: Drug A is superior/non-inferior to Drug B.
2. Ethical Approval and Trial Registration: Obtain approval from Institutional Ethics Committee (IEC) per ICMR guidelines, Helsinki Declaration, and GCP. Register with CTRI (Clinical Trials Registry of India) before enrollment.
3. Define Study Population:
   • Inclusion criteria: Adults with Stage 1/2 hypertension (BP ≥140/90 mmHg), on no antihypertensives or willing to washout.
   • Exclusion criteria: Secondary hypertension, pregnancy, CKD, known allergy to drugs, etc.
   • Calculate sample size (using α=0.05, β=0.20, expected difference in BP reduction).
4. Randomization: Randomly allocate eligible participants to Drug A or Drug B group using computer-generated random number table, block randomization, or stratified randomization (by age, sex, baseline BP). Ensure allocation concealment (sequentially numbered sealed opaque envelopes - SNOSE, or central randomization).
5. Blinding: Double-blind: neither participants nor outcome assessors know which drug is given. Use identical-looking tablets/capsules. Triple-blind includes data analysts.
6. Intervention: Administer Drug A to Group 1 and Drug B to Group 2 for a defined duration (e.g., 12 weeks). Ensure drug compliance monitoring (pill counts, drug logs). Define washout period if crossover design.
7. Outcome Measurement: Primary outcome: mean reduction in systolic/diastolic BP at 12 weeks. Secondary outcomes: side effects, need for rescue medication, quality of life scores. Measure using calibrated sphygmomanometers; standardize measurement conditions.
8. Follow-up and Data Collection: Regular clinic visits (e.g., 4, 8, 12 weeks). Record adverse events, dropouts, and protocol deviations (intention-to-treat principle).
9. Data Analysis: Use appropriate statistical tests (t-test, ANOVA for continuous outcomes; CONSORT guidelines for reporting). Intention-to-treat (ITT) analysis for all randomized participants. Per-protocol analysis as sensitivity analysis.
10. Report: Follow CONSORT statement for reporting RCTs.

Biases and Their Control (3 marks)

---

Q11. Modes of Transmission of Communicable Disease (4+6=10)

Enumeration of Modes of Transmission (4 marks)

1. Direct contact (touching, kissing, sexual contact, biting)
2. Droplet spread (large droplets, <1 metre)
3. Contact with soil (tetanus, hookworm)
4. Inoculation (direct into skin or mucosa)
5. Transplacental (vertical) transmission

1. Vehicle-borne (food, water, blood, fomites, soil)
2. Vector-borne:
   • Mechanical (passive carriage by vector)
   • Biological (agent multiplies/develops in vector)
3. Airborne:
   • Droplet nuclei (dried residue of evaporated droplets, <5 µm, travel >1 metre)
   • Dust particles (dried infective material)
4. Iatrogenic transmission (blood products, transplants, contaminated instruments)

Description of Three Modes with Examples (6 marks)

• Water: Contaminated with faecal matter. Example: Cholera (Vibrio cholerae), typhoid (Salmonella typhi), Hepatitis A, poliomyelitis - all spread via faecally contaminated water (faecal-oral route).
• Food: Example: Salmonella food poisoning from contaminated eggs/poultry; Staphylococcal food poisoning from contaminated custards/creams.
• Blood and blood products: HIV, Hepatitis B and C, CMV.
• Fomites (inanimate objects): Towels, doorknobs, syringes. Example: Trachoma from shared towels; tetanus from contaminated soil on a wound.

• Propagative: Agent multiplies in vector without cyclic development. Example: Plague (Yersinia pestis multiplies in Xenopsylla cheopis flea).
• Cyclo-propagative: Agent undergoes both development and multiplication. Example: Malaria (Plasmodium spp. undergo sporogony in Anopheles mosquito).
• Cyclo-developmental: Agent undergoes development but not multiplication. Example: Filariasis (Wuchereria bancrofti undergoes larval development in Culex mosquito).
• Transovarial: Agent passes from adult vector to offspring via ovaries. Example: Rickettsial diseases in mites.

---

Q12. Define Bias, Confounding Factor, Three Criteria for Causal Association (2+2+6=10)

Definition of Bias (2 marks)

• Selection bias: Systematic difference in who is selected for the study or who participates. Example: Berkson's bias (hospital-based studies over-represent severe cases), volunteer bias.
• Information/Measurement bias: Systematic error in measuring or recording exposures or outcomes. Includes recall bias (cases remember exposures better than controls - common in case-control studies), interviewer bias, observer bias.

Confounding Factor (2 marks)

1. Is associated with the exposure (risk factor) being studied.
2. Is independently associated with the outcome (disease).
3. Is not an intermediate step in the causal pathway between exposure and disease.

Three Criteria for Judging Causal Association (Bradford Hill Criteria) (6 marks)

• Specificity: One cause - one effect relationship (though not always present; smoking causes many diseases).
• Biological gradient (dose-response): Greater exposure leads to greater disease frequency. Example: More pack-years of smoking = higher RR of lung cancer.
• Plausibility: The association is consistent with known biological and pathological mechanisms (e.g., silica particles cause macrophage activation and fibrotic lung disease - biologically plausible for silicosis).
• Coherence: The association does not conflict with known facts about the natural history of the disease.
• Analogy: Similar cause-effect relationships are known (e.g., if one heavy metal causes lung disease, another might too).
• Experiment: Removal of the exposure reduces disease incidence.

---

---

Quick Reference Guide

---

• For Q6, the RR = 120/800 divided by 30/1200 = 0.15/0.025 = 6.0 - workers exposed to silica are 6x more likely to get silicosis.
• For Q8, Hepatitis A is the answer (incubation 15-50 days matches the "two weeks after" fair exposure, and street food/water is the classic route).
• For Q3, the 9-month dose is MR (not just measles) since India switched to MR vaccine.
• All outbreak investigation questions follow the same 8-step Park's framework - verify diagnosis → confirm epidemic → define population → case finding → data analysis → hypothesis → ecological factors → report/control.